Paper · 40086

The substituted benzamides--a novel class of dopamine antagonists.

Jenner P and 1 other. Life Sci, 1979. Cited by 166 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. The substituted benzamides--a novel class of dopamine antagonists. Papers, record 40086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40086

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: The substituted benzamides--a novel class of dopamine antagonists.; PubMed
Journal: Life Sci; PubMed
Year: 1979; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/40086/; PubMed
DOI: https://doi.org/10.1016/0024-3205(79)90559-9; PubMed
The journal: https://conductscience.org/library/journal-index/0375521; PubMed
Citations, by iCite: 166; iCite
Relative citation ratio, by iCite: 8.86; iCite
Revised in PubMed: 2019-07-01; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Jenner P	P
2	Marsden CD	C D

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Antipsychotic Agents	Major topic
Benzamides	Major topic
Dopamine Antagonists	Major topic
Receptors, Dopamine	Major topic
Animals
Antiemetics
Behavior, Animal
Brain
Dopamine
Humans
Hypnotics and Sedatives
Metoclopramide
Movement Disorders
Sulpiride
Tiapamil Hydrochloride

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.

PMID	Title	Journal	Year	In Papers	Source
28,921,163	Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice.	Psychopharmacology (Berl)	2017	https://conductscience.org/library/papers/28921163	PubMed
26,146,874	Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system.	Psychiatr Genet	2015	https://conductscience.org/library/papers/26146874	PubMed
18,801,115	A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.	CNS Neurosci Ther	2008	https://conductscience.org/library/papers/18801115	PubMed
16,097,043	Preventing prolonged post-operative ileus in gastric cancer patients undergoing gastrectomy and intra-peritoneal chemotherapy.	World J Gastroenterol	2005	https://conductscience.org/library/papers/16097043	PubMed
8,800,626	A risk-benefit assessment of sulpiride in the treatment of schizophrenia.	Drug Saf	1996	https://conductscience.org/library/papers/8800626	PubMed
8,325,178	Dopaminergic control of gastric mucosal blood flow in humans. A study with endoscopic laser Doppler flowmetry coupled with gastric submucosal drug injection.	Dig Dis Sci	1993	https://conductscience.org/library/papers/8325178	PubMed
7,812,604	Characterization of the 5-hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle.	Br J Pharmacol	1994	https://conductscience.org/library/papers/7812604	PubMed
7,739,765	Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain.	Neurochem Res	1995	https://conductscience.org/library/papers/7739765	PubMed
7,426,830	Metergoline and cyproheptadine suppress prolactin release by a non-5-hydroxytryptaminergic, non-dopaminergic mechanism.	Br J Pharmacol	1980	https://conductscience.org/library/papers/7426830	PubMed
7,402,361	Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.	Naunyn Schmiedebergs Arch Pharmacol	1980	https://conductscience.org/library/papers/7402361	PubMed

1 to 10 of 29

See all 29 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40086

GET https://conductscience.org/api/papers/v1/40086/cited_by?page=2

API reference For AI assistants